(19)
(11) EP 1 996 697 A2

(12)

(88) Date of publication A3:
21.02.2008

(43) Date of publication:
03.12.2008 Bulletin 2008/49

(21) Application number: 07752647.3

(22) Date of filing: 07.03.2007
(51) International Patent Classification (IPC): 
C12N 1/20(2006.01)
C12P 21/02(2006.01)
(86) International application number:
PCT/US2007/005963
(87) International publication number:
WO 2007/103521 (13.09.2007 Gazette 2007/37)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 07.03.2006 US 779429 P

(71) Applicant: NOVARTIS AG
4056 Basel (CH)

(72) Inventors:
  • MACDONALD, Andrew, C.
    Emeryville, CA 94608-2916 (US)
  • ABU-ABSI, Nicholas
    Emeryville, CA 94608-2916 (US)
  • INLOW, Duane
    Emeryville, CA 94608-2916 (US)
  • POULHZAN, Mary
    Emeryville, CA 94608-2916 (US)

(74) Representative: Graff, Alan 
Novartis Pharma AG Patent Department
4002 Basel
4002 Basel (CH)

   


(54) PREVENTING NORVALINE AND NORLEUCINE MISINCORPORATION IN RECOMBINANT PROTEINS